BIOSTAR PHARM-B 02563·

Gross margin 72.76%--70.27%2.49%86.44%16.17%92.19%5.75% Net margin -489.06%---284.60%204.46%-200.06%84.54%-393.94%193.88% ROE -18.49%---26.22%7.73%-18.18%8.04%-19.73%1.55% ROA -17.33%---24.55%7.23%-15.74%8.81%-16.98%1.23% Revenue growth ----103.03%--7.85%95.18%-53.57%61.42% Attributable profit growth -----18.15%--24.19%42.34%8.58%15.60% Debt-to-assets 6.31%--6.37%0.06%13.41%7.05%13.97%0.56% Current ratio 15.56--14.481.078.835.658.330.51 Operating cash flow / net profit 0.49--0.800.300.780.011.150.37 Operating cash flow / revenue -242.04%---226.27%15.77%-156.67%69.61%-454.13%297.47%

Net margin -365.48%---72.60%292.89% Revenue growth ----147.76%-- Attributable profit growth ----50.79%-- Debt-to-assets ----13.65%-- Current ratio ----8.77--

Revenue 32.82M--66.64M103.03%71.87M7.85%33.36M53.57% Other income and gains 51.38M--31.69M38.31%140.60K99.56%2.94M1989.98% Gross profit 23.88M--46.83M96.08%62.12M32.67%30.76M50.49% Selling and distribution expenses 97.91M--95.40M2.57%61.93M35.08%31.10M49.78% Administrative expenses 51.50M--43.90M14.76%52.34M19.22%34.52M34.04% Net finance costs 71.00K--57.00K19.72%7.48M13014.79%5.81M22.31% Operating profit -160.44M---189.59M18.17%-151.25M20.22%-125.63M16.94% Profit before tax -160.51M---189.64M18.15%-143.78M24.19%-131.44M8.58% Net profit -160.51M---189.64M18.15%-143.78M24.19%-131.44M8.58% Net profit attributable to owners -160.51M---189.64M18.15%-143.78M24.19%-131.44M8.58%

Revenue 14.79M--36.64M147.76% Cost of sales 1.04M--2.56M145.71% Selling and distribution expenses 19.54M--15.90M18.61% Administrative expenses 14.23M--18.24M28.17% Operating profit -55.73M---26.67M52.16% Profit before tax -54.04M---26.60M50.79% Net profit -54.04M---26.60M50.79% Net profit attributable to owners -54.04M---26.60M50.79%

Cash and cash equivalents 60.11M--38.09M36.63%466.64M1125.18%456.77M2.11% Trade and bills receivables 38.95M--15.95M59.06%23.15M45.18%7.16M69.09% Inventories 31.11M--27.27M12.35%31.42M15.23%45.49M44.80% Total current assets 804.67M--633.53M21.27%699.26M10.38%578.03M17.34% Total assets 926.34M--772.34M16.62%913.24M18.24%774.27M15.22% Total current liabilities 51.73M--43.74M15.43%79.16M80.97%69.41M12.32% Total liabilities 58.41M--49.18M15.80%122.50M149.06%108.19M11.68% Equity attributable to owners 867.92M--723.16M16.68%790.75M9.35%666.08M15.77% Total equity 867.92M--723.16M16.68%790.75M9.35%666.08M15.77%

Cash and cash equivalents ----470.41M-- Trade and bills receivables ----20.84M-- Inventories ----48.03M-- Total current assets ----549.71M-- Total assets ----740.99M-- Total current liabilities ----62.69M-- Total liabilities ----101.12M-- Equity attributable to owners ----639.87M-- Total equity ----639.87M--

Net cash from operating activities -79.44M---150.78M89.81%-112.59M25.33%-151.52M34.58% Net cash from investing activities -146.79M--131.28M189.43%53.47M59.27%89.52M67.42% Net cash from financing activities 3.53M---1.13M131.98%208.11M18516.52%-1.25M100.60% Net change in cash -222.69M---20.63M90.73%151.63M834.88%-68.52M145.19%